PELLEGRINO, RAFFAELE
 Distribuzione geografica
Continente #
EU - Europa 3.738
AS - Asia 1.940
NA - Nord America 1.178
SA - Sud America 266
AF - Africa 33
OC - Oceania 3
Totale 7.158
Nazione #
RU - Federazione Russa 2.867
US - Stati Uniti d'America 1.136
SG - Singapore 628
CN - Cina 468
IT - Italia 431
VN - Vietnam 248
HK - Hong Kong 231
BR - Brasile 209
IE - Irlanda 121
KR - Corea 104
DE - Germania 92
BD - Bangladesh 80
IN - India 68
JP - Giappone 49
FR - Francia 48
NL - Olanda 42
GB - Regno Unito 29
AT - Austria 27
FI - Finlandia 20
AR - Argentina 19
MX - Messico 17
CA - Canada 12
ZA - Sudafrica 11
AZ - Azerbaigian 9
ES - Italia 9
EC - Ecuador 8
PL - Polonia 8
CO - Colombia 7
IQ - Iraq 7
PK - Pakistan 7
TR - Turchia 7
PY - Paraguay 6
VE - Venezuela 6
ID - Indonesia 5
MA - Marocco 5
SE - Svezia 5
UA - Ucraina 5
BO - Bolivia 4
KE - Kenya 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
IR - Iran 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
PA - Panama 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 7.158
Città #
Moscow 1.012
Singapore 310
San Jose 269
Hong Kong 221
Naples 213
Santa Clara 169
Hefei 134
Ashburn 125
Dublin 117
Seoul 103
Ho Chi Minh City 86
Beijing 79
New York 62
Hanoi 55
Los Angeles 53
Bengaluru 50
Munich 44
Amsterdam 28
Boardman 25
Orem 25
Rome 25
Dallas 18
Nuremberg 18
Da Nang 17
Haiphong 17
São Paulo 17
Vienna 17
Milan 16
Paris 15
Chandler 14
The Dalles 14
Boydton 13
Council Bluffs 11
Aversa 10
San Francisco 10
Baku 9
Bremen 9
Chicago 9
Frankfurt am Main 9
Helsinki 8
Johannesburg 8
Turku 8
Angers 7
Brooklyn 7
London 7
Manchester 7
Phoenix 7
Biên Hòa 6
Falkenstein 6
Mexico City 6
Mumbai 6
Tokyo 6
Buffalo 5
City of London 5
Memphis 5
Porto Alegre 5
Quảng Ngãi 5
Secaucus 5
Stockholm 5
Warsaw 5
Atlanta 4
Belo Horizonte 4
Cambridge 4
Caserta 4
Castellammare di Stabia 4
Chennai 4
Curitiba 4
Guangzhou 4
Hải Dương 4
Joinville 4
Lappeenranta 4
Nairobi 4
Princeton 4
Quito 4
Roxbury 4
Tashkent 4
Thái Bình 4
Toronto 4
Viterbo 4
Acerra 3
Amman 3
Asunción 3
Athens 3
Boston 3
Brasília 3
Bến Tre 3
Campinas 3
Catania 3
Erbil 3
Guayaquil 3
Houston 3
Itatiba 3
Luxembourg 3
Manassas 3
Ninh Bình 3
Pomezia 3
Resistencia 3
Rio de Janeiro 3
Salvador 3
Shanghai 3
Totale 3.716
Nome #
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity? 219
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 176
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 168
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 166
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 157
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 155
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 154
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 153
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 146
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 145
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 142
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 141
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 140
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 140
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 134
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 132
Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study 131
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 131
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 130
Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam 128
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 128
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis 126
Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report 125
Endoscopic calcium electroporation for unfit-for-surgery bleeding colorectal cancer: the dawn of a new treatment? 125
Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: A post hoc patient-tailored analysis of the "BE-FIT-IBD" study 124
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 124
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 120
Impact of Helicobacter pylori Eradication on Inflammatory Bowel Disease Onset and Disease Activity: To Eradicate or Not to Eradicate? 115
Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey from the Italian society of endoscopic surgery and new technologies (SICE), the Italian society of digestive endoscopy (SIED), the world society of emergency surgery-Italy chapter (WSESit), and the Italian society of surgical endoscopy and digestive diseases (ISSE) 115
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 114
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 113
Cutaneous Kaposi's Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding 113
Author's reply: “Assessing ChatGPT and perplexity AI performance” 112
Editorial: Challenges in Inflammatory Bowel Disease: Current, Future and Unmet Needs 111
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 111
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 106
A Large Language Model Chatbot Would Only Be as Intelligent as the Mind That Uses It! 104
Editorial: Challenges in inflammatory bowel disease: current, future and unmet needs, volume II 103
Clear Cell Renal Carcinoma in an Ulcerative Colitis Patient Under Short-Term Immunosuppressive Therapy: A Case Report 102
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 102
Depression weights in patients with gastric cancer: Bibliometric analysis as a weapon to chart the future of research 101
The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces 100
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 99
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 99
Global treatment of haemorrhoids-A worldwide snapshot audit conducted by the International Society of University Colon and Rectal Surgeons 99
Advancement of haemostatic self-assembling peptides in the treatment of gastrointestinal bleeding: What role for PuraStat®? 95
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19 93
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence 92
Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage 88
Conversational LLM Chatbot ChatGPT-4 for Colonoscopy Boston Bowel Preparation Scoring: An Artificial Intelligence-to-Head Concordance Analysis 88
Emerging space for non-polyethene-glycol bowel preparations in inflammatory bowel disease-related colonoscopy: Veering toward better adherence and palatability 86
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 85
Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The “HERICIUM-UC” Two-Arm Multicentre Retrospective Study 83
Too Many Couch Potatoes Among Middle-Aged Inflammatory Bowel Disease Patients: Findings from the "BE-FIT-IBD-2" Study 78
Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis 78
Editorial: Clinical management of Helicobacter pylori infections 74
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 73
Water-assisted colonoscopy in inflammatory bowel diseases: From technical implications to diagnostic and therapeutic potentials 72
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study 68
When the vermiform appendix resembles a polyp: Be cautious of an intussuscepted appendix polypectomy 66
Machine learning as a tool predicting short-term postoperative complications in Crohn’s disease patients undergoing intestinal resection: What frontiers? 48
Unravelling the pathogenesis of Eosinophilic Esophagitis from genetic predisposition to environmental triggers 28
Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review 9
Relationship between statin use and inflammatory bowel disease: Exploring possible implications 7
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study 7
Sex-Specific Real-Life Profiling in Vedolizumab, Ustekinumab, and Tofacitinib Effectiveness in Ulcerative Colitis 6
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD) 5
Management of Post-Colonoscopy Syndrome with a Nutraceutical Intervention Based on Hericium erinaceus: A Retrospective Two-Arm Multicentre Analysis 5
The eternal dichotomy between early biologic therapy and early surgery in Crohn's disease: which should truly take precedence? 4
Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis 4
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 4
Work Absenteeism in Inflammatory Bowel Disease Patients Related to Patient-Reported Anxiety Levels and Disease Activity: The IBD-GO-WORK Study 3
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 3
Very rare isolated colonic inflammatory cap polyps in a patient with known long-standing ulcerative colitis 2
Concomitant 5‐Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis 1
Management of Pregnancy in Women with Inflammatory Bowel Disease: Positioning Janus Kinase Inhibitors Within Current Evidence 1
Gastric ischemic conditioning before esophagectomy: contemporary practices and insights from an international survey 1
Analysis of possible baseline and treatment-course factors associated with non-remission in patients with Crohn’s disease treated with ustekinumab: a retrospective real-life analysis 1
Totale 7.274
Categoria #
all - tutte 21.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 0 0 0 6 1 0 3 16 11
2022/2023212 5 3 1 3 64 10 4 8 96 9 6 3
2023/2024367 16 19 23 28 48 56 11 11 4 19 38 94
2024/20251.182 10 14 42 62 174 142 145 108 203 95 82 105
2025/20265.476 257 397 340 248 429 2.689 344 252 146 127 208 39
Totale 7.274